Morning:):)! Just wanted to add some more information regarding...

First 3 Last

Share
Profile

Follow
Red bar

1,355 Posts.

816

07/06/18

10:51

Post #: 33555556
Share

Originally posted by TerribleTadpole ↑

That's an awesome piece of detective work Red!

There can be all kinds of pathways through to publication (or rejection). Sometimes the peer reviewers will have feedback that requires work to resolve. It depends on the waiting list. There can also be some editorial decisions made about priorities. Ground-breaking work, time-sensitive findings, work where it is known that priority (i.e. getting published earlier) is important.

There's every possibility that Carrick is miffed with us for being at the Cambridge conference last year, which effectively forced him into making a public statement. I suspect that he didn't intend for that to happen, and is now making extra rigorous efforts to distance himself from any potential allegations that we commissioned the study, or that we have had any influence over its conduct or its findings.

We've been push away past arm's length to beyond the proverbial barge-pole distance!

At least it'll be hard for anybody to argue that the study wasn't independent.

Expand

Morning!

Just wanted to add some more information regarding Frontiers...

Efficient Review
Frontiers’ publishing platform is custom developed. We offer one of the fastest platforms amongst academic publishers. Our Review Forum guides authors, reviewers and editors smoothly through the review process and alerts them when any action is required. This has shortened the average time from submission to final decision to 90 days.

Interesting...

Publication of the double blind study could be just around the corner..

Once the results are published and if the result are good (preliminary results suggest they will be very good) it would be a significant milestones which would see a massive re-rate in the share price as we can Lodge our findings to the FDA. MASSIVE !

Cheers

Red bar

NTI Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 7 more messages in this thread...

First 3 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.001(1.45%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
7.1¢	7.1¢	7.0¢	$16.67K	237.0K

Buyers (Bids)

No.	Vol.	Price($)
3	75250	6.9¢

Sellers (Offers)

Price($)	Vol.	No.
7.0¢	23082	1

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 14.13pm 28/11/2024 (20 minute delay)

NTI (ASX) Chart

Morning:):)! Just wanted to add some more information regarding...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Buyers (Bids)

Sellers (Offers)